Angiomyogenesis for Myocardial Repair
- 1 August 2009
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 11 (8) , 1929-1944
Abstract
The conventional therapeutic modalities for myocardial infarction have limited success in preventing the progression of left ventricular remodeling and congestive heart failure. The heart cell therapy and therapeutic angiogenesis are two promising strategies for the treatment of ischemic heart disease. After extensive assessment of safety and effectiveness in vitro and in experimental animal studies, both of these approaches have accomplished the stage of clinical utility, albeit with limited success due to the inherent limitations and problems of each approach. Neomyogenesis without restoration of regional blood flow may be less meaningful. A combined stem-cell and gene-therapy approach of angiomyogenesis is expected to yield better results as compared with either of the approaches as a monotherapy. The combined therapy approach will help to restore the mechanical contractile function of the weakened myocardium and alleviate ischemic condition by restoration of regional blood flow. In providing an overview of both stem cell therapy and gene therapy, this article is an in-depth and critical appreciation of combined cell and gene therapy approach for myocardial repair. Antioxid. Redox Signal. 11, 1929–1944.Keywords
This publication has 178 references indexed in Scilit:
- Redox Regulation of Stem and Progenitor CellsAntioxidants & Redox Signaling, 2008
- Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantationJournal of Molecular and Cellular Cardiology, 2008
- Genetic Modification of Embryonic Stem Cells with VEGF Enhances Cell Survival and Improves Cardiac FunctionCloning and Stem Cells, 2007
- Bone marrow cells adopt the cardiomyogenic fate in vivoProceedings of the National Academy of Sciences, 2007
- Therapeutic myocardial angiogenesisMicrovascular Research, 2007
- Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseasesInternational Journal of Experimental Pathology, 2007
- Fibroblast growth factor-2 and cardioprotectionHeart Failure Reviews, 2007
- Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2007
- In vitro and in vivo effects of bone marrow stem cells on cardiac structure and functionJournal of Molecular and Cellular Cardiology, 2007
- The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of JNK signalingJournal of Molecular and Cellular Cardiology, 2007